Alex Mijalis
About Alex Mijalis
Alex Mijalis is a Scientist II at Dyno Therapeutics specializing in automation and technology development in the biotechnology sector.
Current Position at Dyno Therapeutics
Alex Mijalis is currently serving as Scientist II at Dyno Therapeutics, located in Cambridge, Massachusetts, United States. He joined the company in May 2021. His expertise at Dyno Therapeutics includes automation and technology development in the biotechnology sector. With a background in both academic and industry settings, Alex brings valuable experience to his current role.
Previous Role at Harvard Medical School
Before joining Dyno Therapeutics, Alex Mijalis worked at Harvard Medical School as a Postdoctoral Fellow from 2018 to 2021. During his three-year tenure in Cambridge, Massachusetts, he was part of George Church’s lab. His research focused on studying new methods for SARS-CoV-2 sequencing and genome editing in mammalian cells.
PhD in Chemical Biology from MIT
Alex Mijalis earned his PhD in Chemical Biology from the Massachusetts Institute of Technology (MIT), where he studied from 2013 to 2018. At MIT, he worked with Brad Pentelute on developing a fully-automated flow chemistry platform for synthesizing peptides and proteins. This experience contributed significantly to his expertise in biopolymer synthesis and laboratory automation.
Bachelor's Degree in Chemistry from Texas A&M University
Alex Mijalis completed his undergraduate studies at Texas A&M University, where he earned a Bachelor’s Degree in Chemistry from 2008 to 2012. This foundational education set the stage for his advanced studies and subsequent professional achievements in the field of chemistry.
Academic Background and Skills
Alex Mijalis has a robust academic background, having studied at prestigious institutions like MIT and Texas A&M University. He specializes in automation and technology development in biotechnology, with considerable experience in biopolymer synthesis, laboratory automation, web development, and high-throughput sequencing. His academic and professional journey has equipped him with unique skills beneficial to both academic and industry settings.